Bedrocan supplies cannabis flowers with 25% THC to the German market.

Bedrocan has just released a version of its 'Bedrocan' cannabis flowers with 25% THC. In a press release, the company reveals that the plant used is the same as the Bedrocan product with 22% THC, Cannabis sativa L. 'Afina', but the tetrahydrocannabinol (THC) content has been increased from 22% to 25%, without altering the genetics or terpene profile. The new product is being marketed under the name Bedrocan® forte, and Germany is the first country to receive it.

Bedrocan® forte is produced at Bedrocan's facilities in Denmark and aims to meet the "growing demand for medicinal cannabis flowers with a higher THC content," according to the press release. "The Danish cultivation team has successfully refined the growing conditions to ensure a higher THC content. This is the same variety that has been marketed under the Bedrocan® brand since 2003 and has a THC content of 22%. The forte version is therefore genetically and chemically identical to Bedrocan®," the statement clarifies.

Compliance with the European Pharmacopoeia monograph for cannabis

Like Bedrocan®, the Bedrocan® forte It complies with the standards of the European Pharmacopoeia monograph. This means that the percentage of active ingredients in the cannabis flower may vary by up to 10% from the percentage indicated on the label. “The terpene profile also remains the same. The physical characteristics of the flower, including structure, density, appearance and aroma, also remain unchanged,” Bedrocan assures.

Active Pharmaceutical Ingredient

Starting this December 2025, Bedrocan® forte will be available as an active pharmaceutical ingredient (API) for pharmaceutical preparations by German pharmacists. “The product is available in bulk packs of 100 and 400 grams, with smaller packs to be made available later.” In Germany, Bedrocan® forte will be distributed by Bedrocan’s new distribution partner, whose partnership will be “announced in due course,” the statement said. Availability in other international markets will follow later.

Bedrocan® forte is produced in accordance with all applicable requirements, including GACP and EU-GMP. “It offers the same pharmaceutical quality as all other cannabis varieties produced by the company. Thanks to highly standardized production methods, each batch is grown under identical conditions (controlled light, temperature, nutrients, etc.), guaranteeing a consistent cannabinoid and terpene profile over time,” the statement concludes.

See the complete terpene profile of Bedrocan® forte here:
bedrocan-terpene-profile

____________________________________________________________________________________________________

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

Laura Ramos

More postsBio

With a degree in Journalism from the University of Coimbra, Laura Ramos has a postgraduate degree in Photography and has been a Journalist since 1998. Winner of the Business of Cannabis Awards in the category "Journalist of the Year 2024", Laura was a correspondent for Jornal de Notícias in Rome, Italy, and Press Officer in the Office of the Minister of Education of the 21st Portuguese Government. She has an international certification in Permaculture (PDC) and created the street-art photography archive “Say What? Lisbon” @saywhatlisbon. Co-founder and Editor of CannaReporter® and coordinator of PTMC - Portugal Medical Cannabis, Laura directed the documentary “Pacientes” and was part of the steering group of the first Postgraduate Course in GxP's for Medicinal Cannabis in Portugal, in partnership with the Military Laboratory and the Faculty of Pharmacy of the University of Lisbon.

• Laura Ramos

  https://cannareporter.eu/author/partner/

  Michael Sassano: "Approvals can be better streamlined and keep the same rigorous quality standards."
• Laura Ramos

  https://cannareporter.eu/author/partner/

  Infarmed grants three ACMs to SOMAÍ's first medicinal cannabis products in Portugal
• Laura Ramos

  https://cannareporter.eu/author/partner/

  Portugal has already spent more than 3 million euros on Epidyolex. Infarmed has been evaluating reimbursement for almost 4 years.
• Laura Ramos

  https://cannareporter.eu/author/partner/

  Ghana wants to implement the “highest taxes in the world” for hemp cultivation: $45,000 per hectare.